Keros Therapeutics, Inc. (KROS) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Keros Therapeutics, Inc. (KROS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $446.3M, listed on NASDAQ, employing roughly 163 people, carrying a beta of 0.95 to the broader market. Keros Therapeutics, Inc. Led by Jasbir S. Seehra, public since 2020-04-08.
Snapshot as of May 14, 2026.
- Spot Price
- $11.04
- ATM IV
- 229.3%
- IV Skew 25Δ
- -1.839
- IV Rank
- 93.3%
- IV Percentile
- 98.8%
- Term Structure Slope
- -0.370
As of May 14, 2026, Keros Therapeutics, Inc. (KROS) at-the-money implied volatility is 229.3%. IV rank is 93.3% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 98.8%. The 25-delta skew is -1.839: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
KROS Strategy Selection at Current Volatility Levels
For Keros Therapeutics, Inc. options at 229.3% ATM IV, high IV rank (93.3%) favors premium-selling structures: credit spreads, iron condors, covered calls, cash-secured puts. The risk: a continued vol expansion through high-rank levels is rare but expensive when it happens. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked KROS volatility skew questions
- What is the current KROS ATM implied volatility?
- As of May 14, 2026, Keros Therapeutics, Inc. (KROS) at-the-money implied volatility is 229.3%. IV rank is 93.3% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is KROS IV high or low historically?
- IV is elevated relative to its 1-year history, conditions that typically favor premium-selling strategies (credit spreads, iron condors, covered calls).
- What does KROS volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Keros Therapeutics, Inc. carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.